Squarepoint’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-73,810
| Closed | -$360K | – | 3072 |
|
|
2024
Q2 | $360K | Sell |
73,810
-9,990
| -12% | -$48.8K | ﹤0.01% | 1878 |
|
|
2024
Q1 | $1.11M | Sell |
83,800
-160,885
| -66% | -$2.14M | ﹤0.01% | 1303 |
|
|
2023
Q4 | $3.41M | Buy |
244,685
+219,155
| +858% | +$3.06M | 0.01% | 805 |
|
|
2023
Q3 | $339K | Buy |
25,530
+10,362
| +68% | +$137K | ﹤0.01% | 1852 |
|
|
2023
Q2 | $284K | Sell |
15,168
-110,272
| -88% | -$2.07M | ﹤0.01% | 1899 |
|
|
2023
Q1 | $1.81M | Buy |
125,440
+82,945
| +195% | +$1.2M | 0.01% | 882 |
|
|
2022
Q4 | $822K | Buy |
+42,495
| New | +$822K | ﹤0.01% | 1204 |
|
|
2022
Q3 | – | Sell |
-40,417
| Closed | -$618K | – | 2550 |
|
|
2022
Q2 | $618K | Buy |
40,417
+11,035
| +38% | +$169K | ﹤0.01% | 1279 |
|
|
2022
Q1 | $670K | Buy |
+29,382
| New | +$670K | ﹤0.01% | 1343 |
|
|
2021
Q3 | – | Sell |
-31,253
| Closed | -$1.88M | – | 2774 |
|
|
2021
Q2 | $1.88M | Buy |
+31,253
| New | +$1.88M | 0.01% | 836 |
|